InDevR Raises $7 million in Series A Financing with Adjuvant Capital
InDevR Raises $7 million in Series A Financing with Adjuvant [...]
InDevR Raises $7 million in Series A Financing with Adjuvant [...]
[Press Release] InDevR launches a new product that could shave weeks [...]
InDevR licenses Mount Sinai influenza antibodies for VaxArray neuraminidase potency [...]
InDevR Receives NIH Support for VaxArray® Pandemic Influenza Vaccine Potency [...]
Dr. Kathy Rowlen attended the IFPMA meeting in London where [...]